Shionogi & Co., Ltd.
Completion of Acquisition of Shares in ViiV Healthcare Ltd.
Shionogi invested 2,125 million USD to acquire 21.7% of shares in ViiV Healthcare Ltd., completing the equity-method affiliate status.
Key Figures
- Investment Amount: 2,125 million USD
- Voting Rights Ratio: 11.7%
- Share Ownership Ratio: 21.7%
AI要約
Overview of M&A
Shionogi & Co., Ltd. announced on January 20, 2026, an additional investment of 2,125 million USD in ViiV Healthcare Ltd., receiving newly issued shares from ViiV. As a result, Shionogi holds a total of 21.7% of shares, including an 11.7% voting rights ratio, and ViiV became an equity-method affiliate.
Future Outlook and Impact on Shareholders
Shionogi positions 'liberation from the threat of infectious diseases' as a key challenge and promotes initiatives against the three major infectious diseases, focusing on HIV infection. Through this investment, Shionogi aims to strengthen partnerships with ViiV and GSK and contribute further to global HIV treatment and prevention. Shareholders are expected to see performance impacts linked to the equity-method affiliate status, though specific financial effects are not disclosed.
Shionogi & Co., Ltd.
Company overview · Stock price · Financial data · All IR
